Atmos Energy Corporation (NYSE:ATO) is included among the 14 Best Dividend Aristocrats to Invest in Heading into 2026.
On December 17, UBS raised its price target on Atmos Energy Corporation (NYSE:ATO) to $174 from $159 and kept a Neutral rating on the shares. The update reflected a more constructive view on valuation, even as broader sector risks remain in focus.
A day earlier, Morgan Stanley moved in the opposite direction. On December 16, the firm downgraded Atmos Energy to Equal Weight from Overweight and cut its price target to $172 from $182. The change came as part of Morgan Stanley’s 2026 outlook for the utilities group. The firm expects utility stock performance to be shaped by data center demand and growth opportunities in 2026, with “no slowing of activity or relief to grid tightness,” according to the research note. Morgan Stanley urged investors to steer clear of political and regulatory risk, particularly in an active election year.
Operationally, Atmos Energy Corporation (NYSE:ATO) continues to lean on a familiar playbook. In its Q4 2025 earnings update, the company said the year marked its 14th consecutive year of executing its strategy centered on safety and reliability. That strategy focuses on upgrading natural gas distribution, transmission, and storage systems. It is not flashy work, but it tends to pay off over time. Capital spending in FY25 totaled $3.6 billion. About 87% of that amount went toward safety and reliability investments.
Shareholders also saw a direct benefit. Atmos Energy Corporation (NYSE:ATO) announced a 15% increase in its quarterly dividend, extending its dividend growth streak to 41 consecutive years. For income-focused investors, that kind of consistency carries weight.
Atmos Energy Corporation (NYSE:ATO) is based in Texas and serves roughly 3.4 million natural gas customers across the southern United States.
While we acknowledge the potential of ATO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 14 Best Pharma Dividend Stocks to Buy in 2026 and 15 Global Dividend Stocks to Diversify Your Portfolio.
Disclosure: None.
-1024x768.jpg "Red Snapper Used as Cudgel by Fed Judge")
